Back
Y-mAbs Therapeutics Stock Price Chart
Sell
35
YMAB
Y-mAbs Therapeutics
Last Price:
11.56
Seasonality Move:
11.04%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and YMAB is experiencing selling pressure, which indicates risk of future bearish movement.
Y-mAbs Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.3 | Sell |
20-day SMA: | 14.49 | Sell |
50-day SMA: | 14.96 | Sell |
200-day SMA: | 9.6 | Buy |
8-day EMA: | 12.64 | Sell |
20-day EMA: | 13.84 | Sell |
50-day EMA: | 14.33 | Sell |
200-day EMA: | 11.25 | Buy |
Y-mAbs Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.92 | Sell |
Relative Strength Index (14 RSI): | 30.78 | Sell |
Chaikin Money Flow: | -233807 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.81 - 16.39) | Sell |
Bollinger Bands (100): | (10.42 - 16.82) | Sell |
Y-mAbs Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Y-mAbs Therapeutics Stock
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 11.60 while YMAB 8-day simple moving average is 12.30, which is a Sell signal.
- The stock price of YMAB is 11.60 while Y-mAbs Therapeutics 20-day SMA is 14.49, which makes it a Sell.
- Y-mAbs Therapeutics 50-day simple moving average is 14.96 while YMAB share price is 11.60, making it a Sell technically.
- YMAB stock price is 11.60 and Y-mAbs Therapeutics 200-day simple moving average is 9.60, creating a Buy signal.
YMAB Technical Analysis vs Fundamental Analysis
Sell
35
Y-mAbs Therapeutics (YMAB)
is a Sell
Is Y-mAbs Therapeutics a Buy or a Sell?
-
Y-mAbs Therapeutics stock is rated a Sell
The current Y-mAbs Therapeutics [YMAB] share price is $11.60. The Score for YMAB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Y-mAbs Therapeutics Stock Info
Market Cap:
509.04M
Price in USD:
11.60
Share Volume:
379.94K
Y-mAbs Therapeutics 52-Week Range
52-Week High:
20.90
52-Week Low:
4.60
Sell
35
Y-mAbs Therapeutics (YMAB)
is a Sell
Y-mAbs Therapeutics Share Price Forecast
-
What is the Y-mAbs Therapeutics stock price today?
The Y-mAbs Therapeutics stock price is 11.60 USD today. -
Will YMAB stock go up or go down?
Y-mAbs Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Y-mAbs Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Y-mAbs Therapeutics is overvalued.
Is Y-mAbs Therapeutics Stock a Buy?
- Y-mAbs Therapeutics share price is 11.60 while YMAB 8-day exponential moving average is 12.64, which is a Sell signal.
- The stock price of YMAB is 11.60 while Y-mAbs Therapeutics 20-day EMA is 13.84, which makes it a Sell.
- Y-mAbs Therapeutics 50-day exponential moving average is 14.33 while YMAB share price is 11.60, making it a Sell technically.
- YMAB stock price is 11.60 and Y-mAbs Therapeutics 200-day simple moving average is 11.25, creating a Buy signal.
Fundamental Analysis of Y-mAbs Therapeutics
Is Y-mAbs Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.07 per share, an increase this year of $0.22 per share, and an increase next year of $0.29 per share.
Technical Analysis of Y-mAbs Therapeutics
Should I short Y-mAbs Therapeutics stock?
- YMAB Moving Average Covergence Divergence (MACD) indicator is -0.92, suggesting Y-mAbs Therapeutics is a Sell
- Y-mAbs Therapeutics Relative Strength Index (RSI) is 30.78, which suggest Y-mAbs Therapeutics is oversold
- The Bollinger Bands (25) for Y-mAbs Therapeutics is (12.81 - 16.39), which suggest Y-mAbs Therapeutics is a Sell
- The Bollinger Bands (100) for Y-mAbs Therapeutics is (10.42 - 16.82), which suggest Y-mAbs Therapeutics is a Sell
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.